Bosch Healthcare Solutions GmbH
PCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling point
more
Stories about Virus
Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease
Asthma in Children: Researchers Envision Novel Drug to Reduce the Risk of the Disease Scientists have reached a milestone in the research of childhood asthma. For the first time, they have clarified how a certain genetic defect in children initially leads to frequent infections and later to asthma. The study, published in the American Journal of Respiratory and ...
moreTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more benfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
moreLandscape of molecular contacts: How the coronavirus SARS-CoV-2 communicates with human cells
moreTechnische Universität München
Viruses help combat antibiotic-resistant bacteria - Cell-free production of bacteriophages
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37533 High resolution images: https://mediatum.ub.tum.de/1678288 NEWS RELEASE Viruses help combat ...
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
moreTechnische Universität München
mRNA containing nanoparticles in the light of neutrons - investigations at FRM II aid in the development of mRNA medications
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37120 High resolution images: https://mediatum.ub.tum.de/1638436 NEWS RELEASE Optimization of mRNA ...
moreTechnische Universität München
A medication against SARS-CoV-2 – new strategy also promises protection against future SARS-CoV-2 variants
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/37076 High resolution images: https://mediatum.ub.tum.de/1637268 NEWS RELEASE A medication against ...
moreNew therapeutic approach against SARS-CoV-2 successfully tested
Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...
moreMicroban® International Announces a New Range of Antiviral Technologies
more- 2
The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics
One documentmore Technische Universität München
The proteins of Covid-19: machine learning assisted structure analysis reveals SARS-CoV-2 virus tactics
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/press-releases/details/36913 High resolution images: https://mediatum.ub.tum.de/1624573 NEWS RELEASE The proteins of Covid-19 ...
moreGold Standard Diagnostics Europe
Novatec and Virotech to become Gold Standard Diagnostics Europe
Dietzenbach (ots) - The two German diagnostics companies Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH are excited to announce that they have joined forces and will now operate together as Gold Standard Diagnostics Europe. Both entities have agreed to consolidate their businesses to better address their partners´ needs and demands. Since the SARS COV 2 outbreak, the companies have been committed to ...
moreTechnische Universität München
New approach identifies T cells in Covid-19 patients
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36882/ NEWS RELEASE New approach identifies T cells in Covid-19 patients Immune cell profile reveals appearance, number and activity level against SARS-CoV-2 T cells play a decisive role in fighting the ...
moreTechnische Universität München
The virus trap: hollow nano-objects made of DNA could trap viruses and render them harmless
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36810/ High resolution images: https://mediatum.ub.tum.de/1616943 NEWS RELEASE The virus trap Hollow ...
more- 2
COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant
One documentmore Technische Universität München
Versatile, fast and reliable: new automated microarray rapid test detects SARS-CoV-2 antibodies
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36762/ High resolution images: https://mediatum.ub.tum.de/1615381 NEWS RELEASE Versatile, fast and reliable SARS-CoV-2 antibody assay Automated microarray ...
moreTechnische Universität München
Animal health through genomics | Feasibility study: Preventing diseases through genome analysis and genome scissors
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36757/ High resolution images: https://mediatum.ub.tum.de/1615373 Animal health through genomics Feasibility study: Preventing diseases ...
moreTechnische Universität München
Four ERC Advanced Grants for TUM scientists
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36588/ NEWS RELEASE EU funding for cutting-edge research Four ERC Advanced Grants for TUM scientists Artificial viruses made with DNA. The human lung as a computer model. A new approach to research on diseases ...
moreFirst pocket inhaler for Covid-19 and other viral mutations
Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
moreTechnische Universität München
Sixfold increase in risk: study shows link between cervical cancer and HIV infection
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center Phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36390/ High resolution images: https://mediatum.ub.tum.de/1585216 NEWS RELEASE Sixfold increase in risk Link between cervical cancer and HIV infection A ...
moreTechnische Universität München
On the trail of the genetic code - Overlapping gene found in SARS-CoV-2
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36345/ NEWS RELEASE On the trail of the genetic code Overlapping gene found in SARS-CoV-2 Viruses are infectious organic structures that spread by transmission and can only multiply within a ...
morenal von minden plans to produce 80 million rapid corona tests per month
moreSwiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
moreTechnische Universität München
Immune response: memory T cells are formed earlier than previously thought
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36297/ NEWS RELEASE How the immune system remembers viruses Immune response: memory T cells are formed earlier than previously thought For a person to ...
moreNew: Combined rapid test for Covid-19 and influenza
moreTechnische Universität München
Coronavirus: door opener facilates cell entry
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...
moreTechnische Universität München
Fighting corona with machine learning
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36254/ NEWS RELEASE The Bavarian Research Foundation is funding five TUM-research projects on Covid-19 Fighting corona with machine learning The Technical University of Munich (TUM) is starting five new research projects that focus on the ...
more
12Next